Sorriso

Landos Biopharma

This company develops oral medicines for patients with autoimmune diseases, specifically targeting inflammatory bowel diseases such as ulcerative colitis and Crohn's disease.

Ensho Therapeutics

This biopharmaceutical company develops oral small molecule therapies to treat patients suffering from inflammatory bowel disease, including ulcerative colitis and Crohn’s disease.

Promakhos Therapeutics

This company develops oral small molecule therapies to treat chronic inflammatory and autoimmune disorders for patients with conditions such as Crohn's disease.

Abivax

This biotechnology company develops an oral small molecule drug to treat patients suffering from chronic inflammatory diseases, including ulcerative colitis and Crohn’s disease.

cAMPfield

The company develops oral biopharmaceutical medicines for patients with immune-mediated inflammatory diseases, specifically focusing on treatments for inflammatory bowel disease.

FF Pharmaceuticals

This company develops monoclonal antibody therapeutics to treat inflammatory and autoimmune diseases for patients with conditions such as Crohn's disease.

Altrubio

This clinical-stage biotechnology company develops antibody therapeutics to treat patients suffering from immunological and inflammatory diseases such as ulcerative colitis.

Aeglea BioTherapeutics

This company develops antibody therapies for patients living with inflammatory bowel disease and other immune-mediated conditions.